Redesign of a rapid, low‐cost <scp>HPV</scp> typing assay to support risk‐based cervical screening and management-Reference-Cited by-同舟云学术

Redesign of a rapid, low‐cost HPV typing assay to support risk‐based cervical screening and management

Published:2022-06-24 Issue:7 Volume:151 Page:1142-1149
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Desai Kanan T.¹^ORCID,Adepiti Clement A.²,Schiffman Mark¹,Egemen Didem¹,Gage Julia C.¹,Wentzensen Nicolas¹^ORCID,de Sanjose Silvia¹³,Burk Robert D.⁴,Ajenifuja Kayode O.²

Affiliation:

1. Clinical Epidemiology Unit, Clinical Genetic Branch, Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville Maryland USA

2. Department of Obstetrics, Gynecology, and Perinatology The Obafemi Awolowo University Ile‐Ife Osun State Nigeria

3. ISGlobal Barcelona Spain

4. Albert Einstein Cancer Center Albert Einstein College of Medicine New York New York USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34151

Reference35 articles.

1. International Agency for Research on Cancer.GCO Cancer Today [Internet]. World Health Organization;2021.https://gco.iarc.fr/today/online-analysis-map?v=2020&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=2&cancer=23&type=1&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&gr. Accessed September 28 2021.

2. Cervical Cancer: An NCD We Can Overcome [Internet].https://www.who.int/dg/speeches/detail/cervical-cancer-an-ncd-we-can-overcome. Accessed July 18 2021.

3. HPV-based cervical cancer screening- facts, fiction, and misperceptions

4. Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

5. The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy;eLife;2024-01-15

2. Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy;eLife;2024-01-15

3. Evaluation of an Isothermal Amplification HPV Assay on Self-Collected Vaginal Samples as Compared to Clinician-Collected Cervical Samples;Diagnostics;2023-10-24

4. Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation;Infectious Agents and Cancer;2023-10-16

5. A rapid HPV typing assay to support global cervical cancer screening and risk‐based management: A cross‐sectional study;International Journal of Cancer;2023-09-29